Pharmafile Logo
Pharmafocus logo
Advanced Search

iX Group buys manufacturing audit company

April 3, 2009
Business Services Rephine

iXGroup, owners of Medix UK, has acquired Rephine, the pharmaceutical audit and consultancy specialists. Rephine was founded in 1998 and …

News

NHS health and social care pilots begin

April 3, 2009
NHS

A raft of pilot schemes designed to bridge gaps between health and social care services started this week. The nationwide …

News

US prescription growth stalls in 2008

April 3, 2009
Sales and Marketing US

US prescription sales growth was just 1.3% in 2008, well down on the typical 5%-plus in recent years, according to …

News

Solvay considering options after Sanofi bid

April 2, 2009
Sales and Marketing Solvay

News

Inflammatory bowel disease care ‘unacceptably’ variable

April 2, 2009
GI, NHS

The standard of care for patients with inflammatory bowel disease in the UK remains "unacceptably" variable. The second national audit …

News

Telehealth awareness reaches tipping point

April 2, 2009
Research and Development, Sales and Marketing digi, healthcare

Analysts Datamonitor believe that telehealth has reached the tipping point in terms of awareness, with IBM following Intel's entrance into …

News

Takeda chooses US base for its global development headquarters

April 2, 2009
Research and Development Takeda

Takeda Pharmaceutical Company is shifting its global development HQ from Japan to the US. The move will see that function …

News

Bayer Schering Pharma restricts UK distribution

April 2, 2009
Manufacturing and Production Bayer

Bayer Schering Pharma has joined the ranks of firms switching to restrictive distribution arrangements in the UK. The pharma company, …

News

Over 40s to have health checks on NHS

April 1, 2009
NHS

Everyone in England aged 40-74 is to get a health check on the NHS in an attempt to identify major …

News

Roche lines up manufacturing and R&D reshuffle

April 1, 2009
Sales and Marketing Genentech, Roche

Genentech's decision to succumb to Roche's $48.8 billion merger bid has signalled a revamp of manufacturing, R&D and other divisions …

News

Cervical cancer awareness is Jade’s legacy

March 31, 2009
Sales and Marketing NHS, vaccines

Jade Goody has left a legacy of hugely increased awareness of cervical cancer in the UK, following her death from …

News

Patients to get counterfeit warning with each prescription

March 31, 2009
Manufacturing and Production counterfeits

New guidance to patients to raise public awareness of fake medicine and its dangers has been launched by the RPSGB …

News

GSW unveils new pan-European comms service

March 31, 2009
Medical Communications GSW

GSW Worldwide, one of the biggest global healthcare advertising agencies has announced the launch of a new pan-European offering. GSW …

News

Merck hikes investment in Irish biologics plant

March 30, 2009
Manufacturing and Production Europe, Ireland

Merck & Co has increased its investment in a new biologic and vaccines facility in Carlow, Ireland, to 220 million …

News

The 2009 Health Bill

March 27, 2009
2009, Darzi, NHS, health bill, healthcare

The 2009 Health Bill is the latest major piece of legislation aimed at transforming the NHS, and introduces a range …

Feature

CROs under pressure as early-stage pipelines dry up

March 27, 2009
Research and Development Pharmsource

There was a sharp slowdown in pharmaceutical outsourcing in the last six months which "really caught a lot of people …

News

GSK pledges further trial transparency

March 26, 2009
Research and Development, Sales and Marketing GSK

GlaxoSmithKline is to make its clinical trials more transparent through a series of moves it believes will facilitate clinical research. …

News

NICE recommends Pfizer’s Sutent

March 26, 2009
Research and Development NICE, Pfizer, Sutent

NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …

News

GSK linked to Allergan takeover

March 26, 2009
Sales and Marketing Allergan, GSK

GlaxoSmithKline may be considering a bid to buy Allergan, the company behind 'cosmaceutical' products such as Botox. Analysts have seized …

News

Grand Designs

March 25, 2009
Sales and Marketing NHS, healthcare, outcomes, patient, pharma

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026